Technology
Health
Pharmaceutical

Spring Bank Pharmaceuticals

$4.66
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.46 (-8.98%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell SBPH and other stocks, options, ETFs, and crypto commission-free!

About SBPH

Spring Bank Pharmaceuticals, Inc. engages in discovery and development of a novel class of therapeutics using its proprietary small molecule nucleic acid hybrid (SMNH) chemistry platform. Its products are used for the treatment of viral infections, inflammatory diseases, and certain cancers. Read More The company was founded by Douglas J. Jensen and Radhakrishnan P. Iyer on October 7, 2002 and is headquartered in Hopkinton, MA.

Employees
29
Headquarters
Hopkinton, Massachusetts
Founded
2002
Market Cap
84.19M
Price-Earnings Ratio
Dividend Yield
Average Volume
70.71K
High Today
$5.10
Low Today
$4.66
Open Price
$5.10
Volume
81.84K
52 Week High
$15.00
52 Week Low
$3.58

Collections

Technology
Health
Pharmaceutical
Banking
Therapy
Finance
2016 IPO
US

SBPH Earnings

-$0.61
-$0.44
-$0.28
-$0.11
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 1, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.